Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8.86%
operating margin TTM
-11.88%
revenue TTM
3.72 Billion
revenue per share TTM
61.27$
valuation ratios | |
|---|---|
| pe ratio | -27.38 |
| peg ratio | -2.82 |
| price to book ratio | 2.55 |
| price to sales ratio | 2.43 |
| enterprise value multiple | 22.95 |
| price fair value | 2.55 |
profitability ratios | |
|---|---|
| gross profit margin | 85.39% |
| operating profit margin | -11.88% |
| pretax profit margin | -16.92% |
| net profit margin | -8.86% |
| return on assets | -3.24% |
| return on equity | -9.25% |
| return on capital employed | -5.44% |
liquidity ratios | |
|---|---|
| current ratio | 1.65 |
| quick ratio | 1.44 |
| cash ratio | 0.54 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 290.33 |
| operating cycle | 357.43 |
| days of payables outstanding | 91.48 |
| cash conversion cycle | 265.95 |
| receivables turnover | 5.44 |
| payables turnover | 3.99 |
| inventory turnover | 1.26 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.48 |
| debt equity ratio | 1.37 |
| long term debt to capitalization | 0.52 |
| total debt to capitalization | 0.58 |
| interest coverage | -2.46 |
| cash flow to debt ratio | 0.26 |
cash flow ratios | |
|---|---|
| free cash flow per share | 22.02 |
| cash per share | 33.71 |
| operating cash flow per share | 22.93 |
| free cash flow operating cash flow ratio | 0.96 |
| cash flow coverage ratios | 0.26 |
| short term coverage ratios | 1.33 |
| capital expenditure coverage ratio | 25.16 |
Frequently Asked Questions
When was the last time Jazz Pharmaceuticals plc (NASDAQ:JAZZ) reported earnings?
Jazz Pharmaceuticals plc (JAZZ) published its most recent earnings results on 05-11-2025.
What is Jazz Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)'s trailing twelve months ROE is -9.25%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Jazz Pharmaceuticals plc (JAZZ) currently has a ROA of -3.24%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did JAZZ's net profit margin stand at?
JAZZ reported a profit margin of -8.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is JAZZ's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.65 in the most recent quarter. The quick ratio stood at 1.44, with a Debt/Eq ratio of 1.37.